MedPath
NMPA Approval

Siltuximab for Injection

国药准字SJ20210031

November 30, 2021

Drug Information

注射用司妥昔单抗

萨温珂

注射剂

100mg/瓶

生物制品

November 30, 2021

November 29, 2026

Company Information

Applicant Company

Beechavenue 54, 1119PW Schiphol-Rijk, Netherlands

Manufacturing Company

Cilag AG

Hochstrasse 201,CH-8200 Schaffhausen,Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用司妥昔单抗 - NMPA 批准文号 | MedPath